Evidence map›Paper›PMID 35566794›Full record

ArticleJournal of clinical medicine2022

Impact of Type 2 Diabetes Mellitus on the Incidence and Outcomes of COVID-19 Needing Hospital Admission According to Sex: Retrospective Cohort Study Using Hospital Discharge Data in Spain, Year 2020.

Jose M de Miguel-Yanes, Rodrigo Jimenez-Garcia, Javier de Miguel-Diez, Valentin Hernández-Barrera, David Carabantes-Alarcon, Jose J Zamorano-Leon, Ricardo Omaña-Palanco, Ana Lopez-de-Andres

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jose M de Miguel-YanesInternal Medicine Department, Hospital General Gregorio Marañón, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), 28007 Madrid, Spain.ORCID 0000-0003-2802-033X
Rodrigo Jimenez-GarciaDepartment of Public Health & Maternal and Child Health, Faculty of Medicine, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IdISSC), 28040 Madrid, Spain.ORCID 0000-0001-5906-9393
Javier de Miguel-DiezRespiratory Department, Hospital General Gregorio Marañón, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), 28007 Madrid, Spain.ORCID 0000-0003-4543-573X
Valentin Hernández-BarreraPreventive Medicine and Public Health Teaching and Research Unit, Health Sciences Faculty, Universidad Rey Juan Carlos, 28922 Alcorcon, Spain.
David Carabantes-AlarconDepartment of Public Health & Maternal and Child Health, Faculty of Medicine, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IdISSC), 28040 Madrid, Spain.ORCID 0000-0001-9897-4847
Jose J Zamorano-LeonDepartment of Public Health & Maternal and Child Health, Faculty of Medicine, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IdISSC), 28040 Madrid, Spain.
Ricardo Omaña-PalancoDepartment of Public Health & Maternal and Child Health, Faculty of Medicine, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IdISSC), 28040 Madrid, Spain.
Ana Lopez-de-AndresDepartment of Public Health & Maternal and Child Health, Faculty of Medicine, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Gregorio Marañón (IdISSC), 28040 Madrid, Spain.ORCID 0000-0001-5551-5181
Universidad Complutense de Madrid · ESUniversidad Rey Juan Carlos · ES

Funding

Convenio V-PRICIT de la Comunidad de Madrid y la Universidad Complutense de Madrid ("Programa de Excelencia para el Profesorado Universitario" INV.AY.20.2021.1E126FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, Instituto de Salud Carlos III) and co-financed by the European Union through the Fondo Europeo de Desarrollo Regional (FEDER, "Una manera de hacer Europa") PI20/00118Universidad Complutense de Madrid. Grupo de Investigación en Epidemiología de las Enfer-medades Crónicas de Alta Prevalencia en España 970970
6 · The paper itself

Abstract

(1) Background: To analyze incidence and in-hospital mortality (IHM) of COVID-19 needing hospital admission in Spain (2020) in patients with T2DM. (2) Methods: We conducted a retrospective cohort study. Using the Spanish Register of Specialized Care-Basic Minimum Database we estimated age-adjusted incidence rates (IR). (3) Results: We included 203,488 patients (56.77% men), of whom 45,620 (22.41%) had T2DM. Age-adjusted IRs/1000 for men with and without T2DM was 12.90 and 5.87, respectively (IRR 2.20; 95% CI 2.18−2.22; p < 0.001), and for women with and without T2DM was 9.23 and 4.27, respectively (IRR 2.16; 95% CI 2.13−2.19; p < 0.001). Crude IHM was 23.86% in people with T2DM, and 15.94% in non-T2DM people (p < 0.001). After matching, intensive-care admission (7.37% vs. 6.15%; p < 0.001) and IHM (23.37% vs. 20.41%; p < 0.001) remained higher in women with T2DM. After matching, IHM among T2DM men was 1.5% higher than among non-T2DM men (24.27% vs. 22.72%; p < 0.001). Men with T2DM had a 34% higher IHM than women with T2DM. Prevalent T2DM increased IHM among women (1.09; 95% 1.03−1.16) and men (1.05; 95% 1.01−1.10). (4) Conclusions: Incidence rates of COVID-19 needing hospital admission were higher in men vs. women, and for people with T2DM vs. non-T2DM. Men had higher IHM beside T2DM status. Prevalent T2DM was associated with higher IHM for both sexes.

Indexed as

COVID-19hospitalizationincidencemortalitytype 2 diabetes mellitus

Identifiers

PMID35566794
PMCPMC9104185
OpenAlexW4229454384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.